Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-02-06 Sale | 2023-02-08 7:35 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Integration Officer | 15,318 | $102.64 | $1,572,197 | 42,337 (Direct) | View |
| 2023-01-31 Sale | 2023-02-02 5:24 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Integration Officer | 1,666 | $110.02 | $183,290 | 28,582 (Direct) | View |
| 2022-08-12 Sale | 2022-08-16 6:44 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Regulatory Officer | 21,533 | $105.95 | $2,281,331 | 26,931 (Direct) | View |
| 2022-02-07 Sale | 2022-02-09 7:04 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Regulatory Officer | 3,382 | $80.48 | $272,168 | 18,731 (Direct) | View |
| 2021-07-27 Sale | 2021-07-29 5:32 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Regulatory Officer | 16,709 | $93.8 | $1,567,336 | 15,801 (Direct) | View |
| 2021-02-10 Sale | 2021-02-12 8:27 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Regulatory Officer | 1,700 | $119.96 | $203,926 | 54,043 (Direct) | View |
| 2021-02-05 Sale | 2021-02-09 9:20 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Regulatory Officer | 4,126 | $116.26 | $479,668 | 69,704 (Direct) | View |
| 2021-01-25 Sale | 2021-01-27 9:30 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Regulatory Officer | 18,670 | $119.97 | $2,239,777 | 76,568 (Direct) | View |
| 2020-11-12 Sale | 2020-11-16 6:21 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Regulatory Officer | 2,257 | $90.73 | $204,776 | 29,002 (Direct) | View |
| 2020-08-05 Sale | 2020-08-07 7:47 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Regulatory Officer | 2,257 | $118.86 | $268,277 | 26,971 (Direct) | View |
| 2020-04-24 Sale | 2020-04-28 8:44 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Regulatory Officer | 1,934 | $99.45 | $192,329 | 24,941 (Direct) | View |
| 2020-02-07 Sale | 2020-02-11 7:21 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Regulatory Officer | 29,984 | $104.52 | $3,133,912 | 40,796 (Direct) | View |
| 2020-02-05 Sale | 2020-02-07 6:47 pm | NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Regulatory Officer | 3,438 | $102.38 | $351,991 | 66,703 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-08-12 Exercise | 2022-08-16 6:44 pm | N/A 2026-02-05 | NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Regulatory Officer | 24,988 | $35.99 | 26,931 (Direct) | View |
| 2022-08-15 Exercise | 2022-08-16 6:44 pm | N/A 2027-02-06 | NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Regulatory Officer | 3,361 | $43.24 | 26,931 (Direct) | View |
| 2022-08-15 Exercise | 2022-08-16 6:44 pm | N/A 2028-02-05 | NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Regulatory Officer | 1,227 | $81.49 | 26,931 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 8:08 pm | N/A 2032-01-31 | NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Regulatory Officer | 24,710 | $0 | 24,710 (Direct) | View |
| 2021-02-08 Option Award(A) | 2021-03-29 06:23 am | N/A 2031-02-08 | NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Regulatory Officer | 35,035 | $0 | 35,035 (Direct) | View |
| 2021-02-10 Exercise | 2021-02-12 8:27 pm | N/A 2026-02-05 | NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Regulatory Officer | 3,400 | $35.99 | 54,043 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-09 9:20 pm | N/A 2031-02-08 | NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Regulatory Officer | 37,194 | $0 | 69,704 (Direct) | View |
| 2021-01-25 Exercise | 2021-01-27 9:30 pm | N/A 2026-02-05 | NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Regulatory Officer | 19,424 | $35.99 | 76,568 (Direct) | View |
| 2021-01-25 Exercise | 2021-01-27 9:30 pm | N/A 2025-02-03 | NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Regulatory Officer | 8,958 | $32.99 | 76,568 (Direct) | View |
| 2020-02-10 Exercise | 2020-02-11 7:21 pm | N/A N/A | NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Regulatory Officer | 13,042 | $32.99 | 40,796 (Direct) | View |
| 2020-02-10 Exercise | 2020-02-11 7:21 pm | N/A N/A | NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Regulatory Officer | 15,927 | $81.49 | 40,796 (Direct) | View |
| 2020-02-10 Exercise | 2020-02-11 7:21 pm | N/A 2025-02-03 | NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Regulatory Officer | 28,969 | $0 | 40,796 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-07 6:47 pm | N/A 2030-02-06 | NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Regulatory Officer | 44,416 | $0 | 66,703 (Direct) | View |